Results 31 to 40 of about 286,873 (209)
Oman Journal of Ophthalmology, 2019 Radiation maculopathy, a subset of significant radiation retinopathy, is one of the most common causes of visual loss following localized, regional, or whole-brain radiotherapy.
Srishti Kamalmani Gulati +2 more
doaj +1 more source
Офтальмохирургия, 2020 Purpose. To evaluate the effectiveness of intravitreal injection of biodegradable intravitreal implant containing dexamethasone (Ozurdex) in patients with resistant diabetic macular edema (DME).Material and methods. The study was conducted of 24 patients
M. M. Bikbov +4 more
doaj +1 more source
Dexamethasone intravitreal implant (Ozurdex) in the treatment of pediatric uveitis [PDF]
Journal of American Association for Pediatric Ophthalmology and Strabismus, 2013 To report our experience using Ozurdex (Allergan, Irvine, CA), a biodegradable intravitreal implant containing of 0.7 mg of dexamethasone approved for use in adults with noninfectious uveitis in adults, in the treatment of pediatric uveitis.The medical records of consecutive patients with noninfectious posterior uveitis who were unresponsive to ...
Monica L, Bratton +2 more
openaire +2 more sources
The Role of Steroids in the Management of Macular Edema from Retinal Vein Occlusion
Oftalʹmologiâ, 2019 Aim: To analyze the effectiveness of intravitreal injection of an anti-VEGF agent (ranibizumab) and an dexametazon implant for the intravitreal injection, in real clinical life. Patients and Methods.
M. V. Budzinskaya +4 more
doaj +1 more source
BMC Ophthalmology, 2017 Background To quantitatively compare short-term hard exudates (HEs) alteration in patients with diabetic macular edema (DME) after intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
Yong Un Shin +5 more
doaj +1 more source
The Role of Adding Intravitreal Dexamethasone Implant to the Standard Management of Serpiginous Choroiditis for Achieving Rapid Remission: A Case Report. [PDF]
Int Med Case Rep JAlmoayad M Makrami,1 Yazeed J Alhaqbani,1 Dhoha M Alhamad,1 Talaat J Hamdi,2 Abdulaziz S Khoshaim1 1Dhahran Eye Specialist Hospital, Eastern Health Cluster, Dhahran, Saudi Arabia; 2Ophthalmology Division, Jeddah University, Jeddah, Saudi ...
Makrami AM +4 more
europepmc +2 more sources
Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Brolucizumab Injection in the Treatment of Diabetic Macular Edema with Hyperreflective Intraretinal Dots: A Retrospective Study. [PDF]
Clin OphthalmolSomnath Chakraborty,1 Jay Umed Sheth2 1Department of Vitreoretinal Services, Retina Institute of Bengal, Siliguri, West Bengal, India; 2Department of Vitreoretinal Services, Shantilal Shanghvi Eye Institute, Mumbai, Maharashtra, IndiaCorrespondence ...
Chakraborty S, Sheth JU.
europepmc +2 more sources
, 2023 Background: Anterior Chamber bleeding without vitreous hemorrhage had been described after the removal of 23G vitrectomy cannulas. We report the case of an anterior chamber bleeding after an intravitreal Dexamethasone implant.
Pasquale Viggiano +17 more
core +1 more source
Revista Médica de Minas GeraisIntroduction: Diabetic macular edema (DME) is characterized by macular exudation and damage to retinal microvasculature. It is estimated that 30% of diabetic patients develop DME during the course of the disease.
Joice Rodrigues Rachid Amin +2 more
doaj +1 more source
Dexamethasone intravitreal implant in the crystalline lens: a case report
Arquivos Brasileiros de Oftalmologia, 2020 This report describes the therapeutic effects and outcomes of an accidental injection of an intralenticular sustained-release dexamethasone implant (Ozurdex®) in three patients with diabetic macular edema. All three patients underwent accidental injections of sustained-release intravitreal dexamethasone implants into the crystalline lens by the same ...
Ertan, Elif +3 more
openaire +3 more sources